Clinical Trial Update: Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) combined with anti-PD1 therapy, chemotherapy, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Microsatellite Stable Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING